GlassScriptPhysician profile
Alison Blevins
NPI 1487883732
$2,267.68
in general payments reported to CMS, 2019-2025
31 companies · $96.68 in 2025
The $96.68 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $387 · 2020: $123 · 2022: $731 · 2023: $717 · 2024: $213 · 2025: $96.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,027.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,026.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $376.47 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $270.31 | 2023-2025 | Myfembree |
| Myovant Sciences INC. | $183.68 | 2022 | |
| Pfizer INC. | $167.91 | 2022-2024 | |
| Coopersurgical, INC. | $160.53 | 2019-2024 | Paragard T 380a, Paragard T 380a |
| Mayne Pharma Commercial LLC | $117.73 | 2022-2023 | |
| Medtronic, INC. | $97.59 | 2022-2023 | Truclear |
| Channel Medsystems, INC. | $92.66 | 2023 | |
| Biogen, INC. | $82.23 | 2024-2025 | Zurzuvae |
| Therapeuticsmd, INC. | $81.84 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $71.89 | 2019-2023 | |
| Agile Therapeutics, INC. | $64.06 | 2022-2023 | Twirla |
| Organon LLC | $59.33 | 2022-2025 | Nexplanon |
| Exeltis, USA INC. | $57.92 | 2019-2025 | Slynd |
| Daiichi Sankyo INC. | $50.88 | 2019-2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $33.99 | 2023-2024 | Aptima, Thinprep 2000 Processor, Third Wave |
| Scynexis, INC. | $33.99 | 2022 | |
| Covidien LP | $29.84 | 2019 | |
| Pharmacosmos Therapeutics INC. | $23.75 | 2023 | Monoferric |
| Olympus America INC. | $22.68 | 2023 | Olympus |
| Monaghan Medical Corporation | $21.88 | 2023 | Aerobika |
| Mission Pharmacal Company | $20.08 | 2020 | |
| Kerecis Limited | $18.35 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Minerva Surgical, INC | $17.88 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $17.79 | 2022 | |
| Applied Medical Resources Corporation | $17.78 | 2023 | |
| Astellas Pharma US INC | $17.58 | 2023 | Veozah |
| Aesculap, INC. | $15.93 | 2019 | |
| Amag Pharmaceuticals, INC. | $14.65 | 2019 | |
| Allergan, INC. | $13.64 | 2019 | |
| Evofem Biosciences, INC. | $12.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alison Blevins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.